Guangzhou Lupeng Pharmaceutical Company Ltd.

This study is testing an oral medication called rocbrutinib for people with mantle cell lymphoma whose cancer has returned or stopped responding to previous treatments, including other similar drugs. About 62 participants will take the medication to see how well it shrinks tumors…